- Home
- KLRS vs RELL Comparison
KLRS vs RELL Comparison
Compare KLRS & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- RELL
- Stock Information
- Founded
- KLRS 2019
- RELL 1947
- Country
- KLRS United States
- RELL United States
- Employees
- KLRS N/A
- RELL N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- RELL Electronic Components
- Sector
- KLRS Health Care
- RELL Technology
- Exchange
- KLRS Nasdaq
- RELL Nasdaq
- Market Cap
- KLRS 129.0M
- RELL 138.8M
- IPO Year
- KLRS N/A
- RELL N/A
- Fundamental
- Price
- KLRS $2.61
- RELL $9.93
- Analyst Decision
- KLRS Buy
- RELL
- Analyst Count
- KLRS 1
- RELL 0
- Target Price
- KLRS N/A
- RELL N/A
- AVG Volume (30 Days)
- KLRS 38.9K
- RELL 41.3K
- Earning Date
- KLRS 08-15-2025
- RELL 07-23-2025
- Dividend Yield
- KLRS N/A
- RELL 2.45%
- EPS Growth
- KLRS N/A
- RELL N/A
- EPS
- KLRS N/A
- RELL N/A
- Revenue
- KLRS N/A
- RELL $204,394,000.00
- Revenue This Year
- KLRS N/A
- RELL $9.48
- Revenue Next Year
- KLRS N/A
- RELL $4.10
- P/E Ratio
- KLRS N/A
- RELL N/A
- Revenue Growth
- KLRS N/A
- RELL N/A
- 52 Week Low
- KLRS $2.28
- RELL $7.57
- 52 Week High
- KLRS $24.15
- RELL $15.51
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- RELL 54.78
- Support Level
- KLRS N/A
- RELL $9.71
- Resistance Level
- KLRS N/A
- RELL $10.06
- Average True Range (ATR)
- KLRS 0.00
- RELL 0.32
- MACD
- KLRS 0.00
- RELL 0.02
- Stochastic Oscillator
- KLRS 0.00
- RELL 62.97
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.